Pictet Asset Management (Switzerland)’s Kyntra Bio KYNB Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.71M	Buy	54,998 +11,447	+26%	+$4.73M	﹤0.01%	822
2023 Q1	$20.3M	Buy	43,551 +23,757	+120%	+$12.6M	0.03%	457
2022 Q4	$7.93M	Buy	19,794 +5,225	+36%	+$2M	0.01%	643
2022 Q3	$4.74M	Buy	14,569 +2,180	+18%	+$702K	0.01%	744
2022 Q2	$3.27M	Buy	12,389 +3,963	+47%	+$1.01M	﹤0.01%	850
2022 Q1	$2.53M	Hold	8,426	–	–	﹤0.01%	933
2021 Q4	$2.97M	Buy	8,426 +4,434	+111%	+$1.38M	﹤0.01%	939
2021 Q3	$1.02M	Buy	+3,992	New	+$1.41M	﹤0.01%	1077

Other funds holding KYNB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s KYNB Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Kyntra Bio (KYNB) stake by 26% in Q2 2023, buying an estimated $4.73M and bringing the position to 54,998 shares worth $3.71M. The position accounts for ﹤0.01% of the portfolio, ranked #822.

Pictet Asset Management (Switzerland) first reported a position in KYNB in Q3 2021 and has held it in 8 quarters since. The position peaked at $20.3M in Q1 2023. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

Pictet Asset Management (Switzerland) held 54,998 shares of Kyntra Bio worth $3.71M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 11,447 Kyntra Bio shares in Q2 2023, an estimated $4.73M.
Kyntra Bio made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #822 holding.
Pictet Asset Management (Switzerland) first reported a position in Kyntra Bio in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Kyntra Bio position peaked at $20.3M in Q1 2023.
152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.